Welcome to the Newron Pharmaceuticals website.
We are a clinical-stage biopharmaceutical company. Our shares are listed on the SIX Swiss Exchange (NWRN). Our mission is to discover, develop and commercialise novel drugs to treat diseases of the Central Nervous System (CNS) and pain.
Discovering and developing innovative therapeutics for CNS disorders
Research & Drug Development
2008
Expert Opin. Investig. Drugs (2008) 17(7):1115-1125
An expert opinion on safinamide in Parkinson's disease
Marco Onofrj , Laura Bonanni & Astrid Thomas
Pain 139 (2008) 293 305
Ralfinamide administered orally before hindpaw neurectomy or postoperatively provided long lasting suppression of spontaneous neuropathic pain-related behavior in the rat.
Zhang SH, Blech-Hermoni Y, Faravelli L, Seltzer Z.
Efficacy and Safety of Ralfinamide in a 8 Week, Randomised, Double Blind, Placebo Controlled, International Trial in Patients with Neuropathic Pain (NP). Ralfinamide 001 Study Group
Ravi Anand
60th Annual Meeting of American Academy of Neurology
April 12 , 19, 2008, McCormick Place West Convention Center , Chicago US
Neuroprotective effects of a novel sodium channel blocker (NW 3381) in rat cortical neurons
P. SALVATI, L. CURATOLO, A. RESTIVO, C. SABIDO-DAVID, S. FRANCISCONI, *C. CACCIA;
38th annual meeting of the Society for Neuroscience - November 15 - 19 in Washington, DC.
Electrophysiological characterization of NW-3381, a potent sodium channel blocker active in animal models for epilepsy and psychiatric disorders
L. FARAVELLI, E. COLOMBO, C. SABIDO-DAVID, P. SALVATI
38th annual meeting of the Society for Neuroscience - November 15 - 19 in Washington, DC.
Antiepileptic properties and antipsychotic potential of NW-3381, a novel potent sodium channel blocker
E. IZZO, M. CALABRESI, *C. SABIDO-DAVID, S. PARINI, A. VEZZANI, M. CARLI, S. BALOSSO, K. WEDZONY, P. SALVATI;
38th annual meeting of the Society for Neuroscience - November 15 - 19 in Washington, DC.
Different efficacy of mood stabilizer and antipsychotic drugs to prevent the hyperactivity induced by amphetamine/chlordiazepoxide mixture or amphetamine alone in mice
AUTHOR BLOCK: A. IERACI, S. MELI, P. SALVATI, *E. IZZO;
38th annual meeting of the Society for Neuroscience - November 15 - 19 in Washington, DC.
Effects of long-term safinamide treatment on dopamine metabolism in motor and nonmotor regions of monkey brain
C. CACCIA, L. GIROLA, P. SALVATI, S. ROSSETTI, R. ANAND
12th confress of European Federation Of Neurological Societies (EFNS). Madrid, Spain, 23-26 August 2008
951427: Safinamide: Modulation of dopaminergic and glutamatergic systems
Carla Caccia, PhD, Patricia Salvati, PhD, Stefano Rossetti, MD and Ravi Anand, MD.
951436: Safinamide: Long-term treatment effects on dopamine metabolism in motor and nonmotor regions of monkey brain
Carla Caccia, PhD, Patricia Salvati, PhD, Stefano Rossetti, MD and Ravi Anand, MD.
The Movement Disorders Society 2008